Revolutionizing Alzheimer’s diagnosis: New insights into blood-brain barrier biomarkers
Alzheimer’s disease, the most prevalent form of dementia, involves the disruption of the blood-brain barrier (BBB), a critical defense mechanism of the brain. Recent research has identified unique molecular changes in the BBB that could pave the way for groundbreaking diagnostic and therapeutic approaches. Understanding the blood-brain barrier’s role in Alzheimer’s The BBB is composed […]
Addressing the disparity: Black Americans in the Alzheimer’s disease battle
The prevalence of Alzheimer’s disease and other dementias within the African American community presents a critical health disparity that demands attention. Studies have shown that older Black Americans are twice as likely to develop Alzheimer’s compared to their White counterparts. This alarming statistic raises questions about the underlying causes and highlights the need for targeted […]